CHRISTIAN S SCHADE
CIK 1214496 · Chairman & CEO · last filed 2026-05-11
CHRISTIAN S SCHADE is a Chairman & CEO who has filed 47 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for IART, was dated May 11, 2026. Across all open-market trades the lifetime net is −$2.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.16M
5
47
-$2.43M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IART | Director | 90,034 | $17.77 | $1.60M | -$2.54M | 25 | 2026-05-11 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Director | — | $0.14 | — | $0 | 4 | 2024-06-21 |
| APRE | Chairman & CEO | 264,246 | $0.69 | $181.3K | $114.1K | 8 | 2022-08-01 |
| NRG | Exec VP & Chief Financial Ofc | 34,916 | $125.47 | $4.38M | $0 | 2 | 2011-03-30 |
| MEDX | SVP & CFO | 0 | $34.49 | $0 | $0 | 5 | 2009-08-31 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | IART | Grant (A) | — | $0 | EDGAR |
| 2025-05-13 | IART | Grant (A) | +26,531 | $0 | EDGAR |
| 2024-06-21 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-13 | IART | Grant (A) | +8,696 | $0 | EDGAR |
| 2024-02-09 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-09 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-12 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-16 | IART | Grant (A) | +4,486 | $0 | EDGAR |
| 2022-08-01 | APRE | Grant (A) | +32,400 | $0 | EDGAR |
| 2022-06-07 | APRE | Tax (F) | −65,770 | -$52.9K | EDGAR |